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Why odds ratio estimates of GWAS are almost
always close to 1.0
Yutaka Yasui

Abstract

“Missing heritability” in genome-wide association studies (GWAS) refers to the
seeming inability for GWAS data to capture the great majority of genetic causes
of a disease in comparison to the known degree of heritability for the disease, in
spite of GWAS’ genome-wide measures of genetic variations. This paper presents
a simple mathematical explanation for this phenomenon, assuming that the heritability information exists in GWAS data. Specifically, it focuses on the fact that
the great majority of association measures (in the form of odds ratios) from GWAS
are consistently close to the value that indicates no association, explains why this
occurs, and deduces two specific forms of epistasis/interaction as its cause. The
implication is that GWAS may be able to recover “missing heritability” if the two
specific forms of epistasis and gene-environmental interaction are fully explored.

1. INTRODUCTION
A genome-wide association study (GWAS) of disease susceptibility
compares “cases” who have developed a disease of interest to “controls” who
have not, within a defined study population, with respect to genetic variations.
Most commonly, the genetic variations examined in GWAS are those of single
nucleotide polymorphisms (SNPs) across the whole genome. As such, a GWAS
is an epidemiological case-control study with SNP genotypes being the
“exposures” of interest that may modify the disease risk. The measure of
association typically used in case-control studies is odds ratio (OR) [Gordis,
2008]. While the underlying odds of developing the disease in a defined time
period (i.e., the case-control ratio) is fixed by the case-control study design, and
thus not estimable, its ratio between two groups with and without a hypothesized
cause of the disease is estimable [Cornfield, 1951]. Specifically in GWAS, ORs
of developing the disease are estimated between individuals with and without
certain genotypes of SNPs: departures of the ORs from 1.0 indicate that
corresponding genotypes of SNPs (or the regions of genome they represent) are
associated with the disease risk.
GWAS has become a major research framework, often conducted as
multi-country collaborative projects with great resource requirements, aiming to
identify regions of human genome whose variations across subjects are associated
with risk of various diseases. This aim has been accomplished only partially,
however, even for diseases that have been investigated by a large number of
GWASs such as Crohn’s Disease. Specifically, the known degree of genetic
contributions to the risk of developing a particular disease (i.e., the “heritability”),
known from other types of studies (e.g., family studies), is explained poorly by
GWAS findings, where only a small fraction of the known degree of the
“heritability” are attributable to SNP variations discovered by GWASs. This
problem is referred to as the “missing heritability” problem and its potential
causes have been debated widely [Manolio et al., 2009; Goldstein, 2009].
The aim of this paper is to attempt to explain the “missing heritability”
problem with precise statistical reasoning and provide a potential direction with
which the problem can be tackled. The strategy is to apply a key statistical
theorem on ORs in the population, not in the sample, namely, the collapsibility
theorem for the analysis of contingency tables, to show that the “missing
heritability” problem is due to two specific forms of interaction that are not
widely assessed in GWAS analysis. The implication of this work is that,
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assuming GWAS data contain the “heritability” information, its extraction must
target these specific forms of interaction.

2. COLLAPSIBILITY AND MARGINAL ODDS RATIOS
Analysis of GWAS data is typically performed for a single SNP, one at a
time, without involving any other SNPs or non-genetic factors. The salient
systematic feature of GWAS findings, regardless of diseases and populations
studied, is that the great majority of resulting OR estimates are close to 1.0.
These near-null OR estimates lead to, and is the essence of, the “missing
heritability” problem of GWAS. This characteristic of GWAS OR estimates
cannot be attributable to stochastic properties of the OR estimation, including
statistical power: if it could, OR estimates would be highly variable and not
consistently close to 1.0. Thus, underlying ORs in the population must also be
close to 1.0. If the underlying biology in the population were such that there is
only one causal factor for the disease and it is the genotype of a single SNP (or
the region of genome it represents), the marginal OR of the disease defined for the
SNP genotype in the population, ignoring all the other SNPs and non-genetic
factors, would represent the underlying biological disease-SNP association
accurately. The underlying biology of complex diseases studied in GWAS,
however, is expected to involve multiple SNPs and non-genetic factors. With the
existence of multiple causal factors, the marginal OR of the disease defined for
one of the causal factors would not represent accurately the extent and mechanism
of the underlying disease biology involving the factor.
Statisticians have proven theorems that specify exact circumstances under
which one can ignore other relevant factors and assess the marginal association
between two variables accurately (when all variables are categorical) [Simpson,
1951; Whittemore, 1978; Ducharme and LePage, 1986]. Using relevant terms in
GWAS, one of such theorems can be stated as follows.
The SNP-disease association measured by the marginal OR between
genotypes of a single SNP and the case-control status of a disease, without
considering any other variable, is equal to the association measured by the
conditional OR between these two variables in any subgroup defined by a third
variable (and therefore the third variable can be ignored in the assessment of the
SNP-disease association) if and only if the SNP genotype is independent of the
third variable in both cases and controls, or the third variable is independent of
the case-control status in all SNP-genotype groups.
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Note that “the third variable” can be a combination of multiple variables
including SNPs and non-genetic factors. According to the theorem, the marginal
OR calculated for the genotype of a single SNP, ignoring all the other relevant
factors, genetic and non-genetic, is accurately representing the SNP-disease
association in any subgroups defined by the other relevant factors, if and only if
all the other relevant factors are independent of the SNP genotype in both cases
and controls (or the trivial case holds where there is no other factor other than the
SNP associated with the disease). This theorem can be proven for the GWAS
scenario, using elementary algebra of OR as shown in Appendix A. Without loss
of generality, we will consider hereafter binary genotypes of a SNP
(corresponding to dominant or recessive inheritance).
Given that even the largest OR estimates are close to 1.0 in the great
majority of GWASs of disease susceptibility and they do not explain the full
extent of known degrees of disease heritability, the theorem suggests that the
violation of its condition is the norm in the underlying biology of the complex
diseases studied in GWAS. How is the theorem’s condition violated? In a
properly-designed case-control GWAS, Mendelian Randomization [Clayton and
McKeigue, 2001] implies that genotypes of a SNP are independent of “the third
variable” in controls, unless “the third variable” is genetic and in the region of
linkage disequilibrium (being correlated) with the SNP. Thus, the theorem’s
condition that is violated has to be the independence of the SNP genotype and
“the third variable” in cases. In other words, the theorem identifies a potential
source of the “missing heritability” problem to be the dependence of the SNP
genotype and “the third variable” in cases.

3. PRECISE CONDITIONS THAT MAKE ODDS RATIOS CLOSE
TO 1.0
Let us quantify this dependence in cases and identify when the marginal
OR estimate of a SNP gets close to 1.0 in spite of its strong association (not as a
single SNP, but together with “the third variable”) with the disease. To simplify
the discussion without loss of generality, consider a binary “third variable” and
indices i and j for the ith genotype of the SNP of interest (i = 0, 1) and the jth
category of “the third variable” (j = 0, 1).
The independence of the SNP genotype and “the third variable” in cases
implies that there is no interaction between the two, i.e., the conditional OR of the
disease comparing the SNP genotype 1 vs. 0, conditioned on “the third variable”, j
= 0 or 1, does not change between the categories of “the third variable”, i.e.,
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OR1|j = OR1|0 , where OR1|j is the conditional OR of the disease comparing the SNP
genotype 1 vs. 0, conditioned on being in the jth category of “the third variable”.
Thus, the departure from the independence can be expressed by
OR1|1 = OR1|0 (1 + δ ) with non‐zero δ (>‐1). Then, as shown in Appendix B, the
marginal OR, denoted by OR, that is estimated in the single-SNP GWAS analysis
ignoring “the third variable” is given by:

⎪⎧
OR = OR1|0 × ⎨1 + δ
⎪⎩

⎛
p × odds00 ⎞ ⎪⎫
/ ⎜ 1 + 00
⎟⎬ ,
p01 × odds01 ⎠ ⎭⎪
⎝

where pij be the proportion of subjects with the ith genotype of the SNP and the jth
category of “the third variable” among controls, and oddsij be the ratio of this
proportion among cases to pij , the same proportion among controls.
According to the equation, the marginal OR is close to 1.0 systematically
in the population, in spite of the SNP’s association with the disease risk in only
two scenarios: (A) OR1|0 is greater than 1.0 but δ is negative and thus the
marginal OR gets attenuated towards 1.0; and (B) while OR1|0 is close to 1.0,

OR1|1 is not with a positive δ, but the factor in the parenthesis ( ) of the equation is
large and thus the marginal OR gets close to 1.0. These correspond to the
following two specific forms of interaction.

Interaction of Redundancy/Masking
This form occurs when the SNP is strongly associated with the increased
disease risk in the absence of “the third variable” ( OR1|0 is greater than 1.0), but
the presence of “the third variable” masks the SNP-disease association. The
marginal OR gets close to 1.0 under this scenario if “the third variable” is
prevalent (in the SNP=0 group) and/or strongly positively associated with the
disease (in the SNP=0 group).
For example, under so-called “genetic heterogeneity”, two or more SNPs
may be associated with disease risk such that either is sufficient to modify disease
risk, but neither is necessary. They are redundant and the presence of both does
not result in the sum of the two effects. These are illustrated by broken lines in
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Figure
1.
As
a
specific
numerical
example,
OR1|0 = 10.0 = odds01 / odds00 , δ = −0.9, and p01 = γ × p00 would yield the marginal
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OR = 1.8, 1.2, and 1.1 for γ = 1, 5, and 9, respectively. The OR of 10.0 for each
SNP in the absence of the other can be attenuated to the marginal OR that is close
to 1.0, depending on the prevalence of the other.
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Prevalence of the third variable
Figure 1. Marginal ORs of SNP-disease associations under the
epistasis/interaction of redundancy/masking. The conditional ORs of SNPdisease associations in the absence of “the third variable” are set to be 2.0 (black),
10.0 (blue), and 50.0 (red). The solid lines show the marginal ORs when “the
third variable” itself does not modify disease risk, while the broken lines show the
marginal ORs when “the third variable” and the SNP modify disease risk by the
same multiplicative factor in the absence of the other. These show that the
prevalence of “the third variable” has to be very high for the marginal ORs to
become below 1.5 (the green broken-dotted line) as seen in GWAS.
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Another example may involve a prevalent factor, genetic and/or nongenetic, as “the third variable” which masks SNPs’ associations with disease risk.
In this case, the prevalent factor does not have to be associated with the disease
risk so long as it is prevalent. These are illustrated by solid lines in Figure 1. As
a
specific
numerical
example,
OR1|0 = 10.0, odds01 / odds00 = 1.0, δ = −0.9, and p01 = γ × p00 would yield the
marginal OR = 1.8, 1.4, and 1.2 for γ = 10, 20, and 50, respectively. The OR of
10.0 for the SNP in the absence of the prevalent factor that is not associated with
the disease risk, can be attenuated to the marginal OR that is close to 1.0,
depending on the prevalence of the prevalent factor. This example may be more
plausible than the previous one above because the previous example puts the
majority of the population at higher risk. See Table 1 for a real-data example
from a GWAS study of Crohn’s Disease [WTCCC, 2007]. Specifically, in the
Crohn’s Disease GWAS data of Wellcome Trust Case Control Consortium, the
marginal OR estimate of the disease for the CC genotype of rs6518932 is 1.01.
The corresponding conditional OR estimate, given “the third variable”
(rs5999715’s genotype) being equal to AA/AC, is 61.80. The strong SNP-disease
association in the absence of “the third variable”, indicated by the conditional OR
estimate of 61.80, is masked by the prevalent “third variable” (99.4% of the
control group is rs5999715=CC) into the marginal OR of 1.01.
Table 1. An illustration of “interaction of masking” with real GWAS data
Disease

Marginal

Overall
1 (CC)
SNP
rs6518932
0 (TT/TC)

Third
(rs5999715)

Control

1243

2084

1 (CC)

rs6518932 0 (TT/TC)

OR

1.01
502

851

variable Disease

= 0 (AA/AC)
SNP

Case

Conditional

Case

Control

206

5

8

12

OR1|0

61.80
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Note that, while the discussion above, including Figure 1, Table 1, and the
specific numerical examples considered risk-elevating SNP-disease associations
only, the same attenuation of marginal ORs occurs for risk-reducing SNP-disease
associations: this also applies to Figure 2 and its numerical examples below.
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Prevalence of the third variable
Figure 2. Marginal ORs of SNP-disease associations under the
epistasis/interaction of concurrence. The conditional ORs of SNP-disease
associations in the presence of “the third variable” are set to be 2.0 (black), 10.0
(blue), and 50.0 (red). The solid lines show the marginal ORs when “the third
variable” itself does not modify disease risk in the low-risk genotype group of the
SNP: this is the mirror image of the solid lines in Figure 1. The two broken lines
above and below each solid line represent the same scenario as the solid line
except that “the third variable” increases and decreases, respectively, disease risk
by two-fold in the low-risk genotype group of the SNP. The prevalence of “the
third variable” has to be less than 5.6% to make the marginal OR less than 1.5,
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when the conditional ORs are 10.0 and 1.0 in the presence and absence,
respectively, of “the third variable.”

Interaction of Concurrence
This form occurs when the SNP is strongly associated with the disease risk
only in the presence of a third factor (i.e., both factors are required). The
marginal OR gets close to 1.0 under this scenario if “the third variable” is
uncommon (in the SNP=0 group) and/or strongly negatively associated with the
disease (in the SNP=0 group). For example, modification of disease risk may
require multiple factors, genetic and/or non-genetic, to take place concurrently,
similar to the set of multiple mutations required in multistage carcinogenesis for a
cancerous cell to develop. These are illustrated in Figure 2. As a specific
numerical
example,
OR1|0 = 1.0 = odds01 / odds00 , OR1|1 = 10 (δ = 9), and p01 = γ × p00 would lead to the
marginal OR = 1.8, 1.4, and 1.2 for γ = 1/10, 1/20, and 1/50, respectively, in spite
of each factor’s 10-fold modification of disease odds in the presence of the other.
The two forms of interaction are, in fact, equivalent: the same
phenomenon can be described in two different ways. For example, masking by a
prevalent “third variable” of the SNP-disease association in the absence of “the
third variable” can be considered as the concurrence of SNP and the uncommon
absence of “the third variable”. Also, one’s risk elevation can be derived from the
other’s risk reduction by switching the coding between 0 and 1 for the SNP and
that for the third variable. Nevertheless, it is useful to discuss both forms at least
initially as the equivalence is not immediately clear.

4. CONCLUSION
In summary, the statistical reasoning above shows that the “missing
heritability” problem may be solved if the specific form of interaction, namely,
the interaction of concurrence with relatively uncommon genetic and non-genetic
factors, is fully explored, assuming that heritability information itself is not
missing in GWAS data. The specific form of interaction has been largely
unexplored in GWAS where the standard data analysis examines each single SNP
one at a time. In particular, if the etiology of the disease is known to have
substantial genetic components and it is explained little by GWAS findings,
exploration of interaction of concurrence with relatively uncommon genetic and
non-genetic factors, may recover the “missing heritability” and identify genetic
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components with appreciable ORs. While existing tools such as logic regression
[Ruczinski et al., 2003] may be useful for such explorations of GWAS data, it
would be advantageous if tools are developed specifically targeting the interaction
of concurrence with relatively uncommon genetic and non-genetic factors.

5. SUPPLEMENTARY MATRIALS
APPENDIX A: Proof of the theorem for GWAS scenario
Let pij and oddsij be the proportion among controls and the odds of
disease, respectively, with the ith genotype of the SNP of interest (i = 0, 1) and the
jth category of “the third variable” (j = 0, 1, …, J). The marginal OR of the
disease comparing the SNP genotype 1 vs. 0, ignoring the third variable, and the
corresponding conditional OR OR1|j in the jth category of “the third variable” are
given by:

OR =

J

J

j =0
J

j =0
J

j =0

j =0

(∑ p1 j × odds1 j ) / ∑ p1 j
(∑ p0 j × odds0 j ) / ∑ p0 j

, OR1|j = odds1 j / odds0 j .

The condition of the theorem is separated into:
(1) Non trivial case where the SNP genotype is independent of the third variable
in both cases and controls; and
(2) Trivial case where the third variable is independent of the case-control status
in both SNP-genotype groups.
Proof of sufficiency
(1) Non trivial case
If the SNP and “the third variable” are independent in controls, then
p1 j × p00 = p0 j × p10 for all j.
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If the SNP and “the third variable” are independent in cases, then
(p1 j × odds1 j ) × (p00 × odds00 ) = (p0 j × odds0 j ) × (p10 × odds10 ) for all j.
Therefore, odds1 j / odds0 j (= OR1|j ) = odds10 / odds00 (= OR1|0 ) for all j, and
also

OR =

J

J

j =0
J

j =0
J

j =0

j =0

(∑ p1 j × odds1 j ) / ∑ p1 j
(∑ p0 j × odds0 j ) / ∑ p0 j

= OR1|j for all j.

(2) Trivial case
If “the third variable” and the disease are independent in both SNP
genotype groups, then odds1 j / odds10 = odds0 j / odds00 = 1 which implies
OR1|j = OR1|0 = OR.

Proof of necessity
If

OR =

OR = OR1|j (= odds1 j / odds0 j )

J

J

j =0
J

j =0
J

j =0

j =0

(∑ p1 j × odds1 j ) / ∑ p1 j
(∑ p0 j × odds0 j ) / ∑ p0 j

= OR ×

for

all

J

J

j =0
J

j =0
J

j =0

j =0

j,

then

(∑ p1 j × odds0 j ) / ∑ p1 j
(∑ p0 j × odds0 j ) / ∑ p0 j

J

J

J

J

j =0

j =0

j =0

j =0

and, therefore, (∑ p1 j × odds0 j ) / ∑ p1 j = (∑ p0 j × odds0 j ) / ∑ p0 j . This is satisfied
if and only if:
J

J

j =0

j =0

either odds0 j = odds00 or p1 j / ∑ p1 j = p0 j / ∑ p0 j for all j, that is, either
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(2) Trivial case holds because odds0 j = odds00 for all j which implies
odds1 j = odds10 from OR = OR1|j (= odds1 j / odds0 j ) , and therefore “the third

variable” is independent of the case-control status in both SNP-genotype groups;
or
J

J

j =0

j =0

(1) Non-trivial case holds because p1 j / ∑ p1 j = p0 j / ∑ p0 j for all j, implying the
independence

of

the

J

J

j =0

j =0

SNP

and

“the

third

variable”

in

controls

( p1 j / p0 j = ∑ p1 j / ∑ p0 j ), and the same applies to cases because of
OR = OR1|j (= odds1 j / odds0 j ) ,

which

J

J

j =0

j =0

implies

( p1 j × odds1 j / (p0 j × odds0 j ) = ∑(p1 j × odds1 j ) / ∑(p0 j × odds0 j ) ).
APPENDIX B: Marginal OR ignoring “the third variable” when the condition of
the theorem is not met in cases
For ease of the discussion without loss of generality, we will consider the
scenario with a binary third variable (j=0, 1). Based on the Mendelian
Randomization, the SNP and “the third variable” are independent in controls, i.e.,
p11 × p00 = p01 × p10 . Let OR1|0 = odds10 / odds00 denote the conditional OR of the
disease comparing the SNP genotype 1 vs. 0, in the category 0 of the third
variable. Then, the marginal OR ignoring “the third variable” is given
b
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(p11 × odds11 + p10 × odds10 ) / (p11 + p10 )
(p01 × odds01 + p00 × odds00 ) / (p01 + p00 )
p
(p11 × odds11 + p10 × odds10 ) / 10
p00
=
(p01 × odds01 + p00 × odds00 )
(p × odds11 + p00 × odds10 )
= 01
(p01 × odds01 + p00 × odds00 )
(p × OR1|0 × odds01 + p00 × OR1|0 × odds00 )
δ (p01 × OR1|0 × odds01 )
= 01
+
if OR1|1 = OR1|0 (1 + δ )
(p01 × odds01 + p00 × odds00 )
(p01 × odds01 + p00 × odds00 )

OR =

⎪⎧
= OR1|0 × ⎨1 + δ
⎩⎪

⎛
p × odds00
/ ⎜ 1 + 00
p01 × odds01
⎝

⎞ ⎪⎫
⎟ ⎬.
⎠ ⎭⎪
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